IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q2 2019 Holdings

Filed 2019-08-06 | 54 holdings | $3.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$267.0K10,0008.9%
Corcept Therapeutics Inc(CORT)COM218352102$558.0K50,00018.6%
Arvinas Inc(ARVN)COM04335A105$660.0K30,00022.0%
Biogen Inc(BIIB)COM09062X103$1.2M5,00038.9%
PreviousPage 2 of 2